Contineum Therapeutics

CTNMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$565.822 M

$15.04 -2.02%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$60.0M

Loss-making

Shares outstanding

23,099,173

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#199CorMedixCRMD$583.7M
#200ArvinasARVN$572.1M
#201Contineum TherapeuticsCTNM$565.8M
#202Sagimet BiosciencesSGMT$559.5M
#203Silence TherapeuticsSLN$559.3M

Where these numbers come from

Share counts and financials for Contineum Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.